A Phase II Study of Sequential Capecitabine Plus Oxaliplatin Followed by Docetaxel Plus Capecitabine in Patients With Unresectable Gastric Adenocarcinoma: The TCOG 3211 Clinical Trial

Fluorouracil and platinum are considered the standard treatment options for advanced gastric cancer. Docetaxel is also an effective agent and it shows no cross-resistance with fluorouracil and platinum. The combination treatment of docetaxel with fluorouracil and platinum has been explored, but it d...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ming-Huang, Lin, Johnson, Hsiao, Chin-Fu, Shan, Yan-Shen, Chen, Yeu-Chin, Chen, Li-Tzong, Liu, Tsang-Wu, Li, Chung-Pin, Chao, Yee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998286/
https://www.ncbi.nlm.nih.gov/pubmed/26817912
http://dx.doi.org/10.1097/MD.0000000000002565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998286/
https://www.ncbi.nlm.nih.gov/pubmed/26817912
http://dx.doi.org/10.1097/MD.0000000000002565

Ejemplares similares